Multisite study of the relationships between antemortem [

Alzheimer's disease neuropathologic changes CERAD Centiloid Harmonization Neuropathology Pittsburgh compound-B Positron emission tomography Thal Threshold β-amyloid

Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
02 2019
Historique:
received: 04 04 2018
revised: 08 07 2018
accepted: 03 09 2018
pubmed: 23 10 2018
medline: 11 4 2020
entrez: 23 10 2018
Statut: ppublish

Résumé

We sought to establish the relationships between standard postmortem measures of AD neuropathology and antemortem [ Four centers contributed 179 participants encompassing a broad range of clinical diagnoses, PET data, and autopsy findings. CL values increased with each CERAD neuritic plaque score increment (median -3 CL for no plaques and 92 CL for frequent plaques) and nonlinearly with Thal Aβ phases (increases were detected starting at phase 2) with overlap between scores/phases. PET-pathology associations were comparable across sites and unchanged when restricting the analyses to the 56 patients who died within 2 years of PET. A threshold of 12.2 CL detected CERAD moderate-to-frequent neuritic plaques (area under the curve = 0.910, sensitivity = 89.2%, specificity = 86.4%), whereas 24.4 CL identified intermediate-to-high AD neuropathological changes (area under the curve = 0.894, sensitivity = 84.1%, specificity = 87.9%). Our study demonstrated the robustness of a multisite Centiloid [

Identifiants

pubmed: 30347188
pii: S1552-5260(18)33523-4
doi: 10.1016/j.jalz.2018.09.001
pmc: PMC6368897
mid: NIHMS1507069
pii:
doi:

Substances chimiques

2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole 0
Aniline Compounds 0
Thiazoles 0

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-216

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS017950
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG054076
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG016574
Pays : United States
Organisme : NIA NIH HHS
ID : K24 AG053435
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG027859
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG027984
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG019724
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG021028
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG031563
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010129
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG045611
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG025204
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG034570
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG041851
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG023501
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005142
Pays : United States
Organisme : NIA NIH HHS
ID : K24 AG045333
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG056366
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG038791
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG054449
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG058676
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG011378
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG049638
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG012435
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG032306
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005133
Pays : United States
Organisme : NIA NIH HHS
ID : K23 AG031861
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG025516
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS097495
Pays : United States

Informations de copyright

Copyright © 2018 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Références

Lancet Neurol. 2012 Aug;11(8):669-78
pubmed: 22749065
Brain. 2008 Jun;131(Pt 6):1630-45
pubmed: 18339640
Alzheimers Dement (Amst). 2017 Jul 01;9:25-34
pubmed: 28795133
Arch Neurol. 2005 Sep;62(9):1402-8
pubmed: 16157747
Neurology. 1980 Aug;30(8):820-5
pubmed: 7191064
Adv Pharmacol. 2012;64:27-81
pubmed: 22840744
Neurology. 2017 Nov 14;89(20):2031-2038
pubmed: 29046362
Acta Neuropathol. 2012 Mar;123(3):433-47
pubmed: 22271153
Neurology. 2011 Dec 6;77(23):2034-42
pubmed: 22131541
Neurology. 1991 Apr;41(4):479-86
pubmed: 2011243
Brain. 2015 Jul;138(Pt 7):2020-33
pubmed: 25953778
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4
pubmed: 25443857
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1398-407
pubmed: 24647577
Nat Commun. 2017 Oct 31;8(1):1214
pubmed: 29089479
Brain. 2011 Sep;134(Pt 9):2565-81
pubmed: 21908872
Brain. 2010 Feb;133(Pt 2):512-28
pubmed: 20080878
Neuroimage Clin. 2016 Nov 11;13:130-137
pubmed: 27981028
Lancet Neurol. 2012 Dec;11(12):1057-65
pubmed: 23137949
Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S85-8
pubmed: 9330992
Am J Pathol. 2001 Jun;158(6):2165-75
pubmed: 11395394
Arch Neurol. 2009 Dec;66(12):1537-44
pubmed: 20008660
Neurology. 2013 Mar 5;80(10):890-6
pubmed: 23446680
Neuroimage. 2015 Feb 15;107:55-64
pubmed: 25485714
Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1104-19
pubmed: 21336694
Neurobiol Aging. 2012 May;33(5):878-85
pubmed: 20961664
Brain. 2012 Jul;135(Pt 7):2126-39
pubmed: 22628162
Brain. 2016 Sep;139(Pt 9):2540-53
pubmed: 27401520
Neuroimage. 2013 May 1;71:207-15
pubmed: 23353602
JAMA Neurol. 2014 Feb;71(2):195-200
pubmed: 24378418
PLoS One. 2016 Mar 24;11(3):e0152082
pubmed: 27010959
Brain. 2017 Dec 1;140(12):3329-3345
pubmed: 29053860
Alzheimers Dement. 2017 Mar;13(3):205-216
pubmed: 27697430
JAMA Neurol. 2015 Mar;72(3):287-94
pubmed: 25622185
Alzheimers Dement. 2012 Jan;8(1):1-13
pubmed: 22265587
J Nucl Med. 2016 Aug;57(8):1233-7
pubmed: 26912446
Brain. 2015 May;138(Pt 5):1370-81
pubmed: 25805643
Arch Neurol. 2011 Feb;68(2):232-40
pubmed: 21320990
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2053-2059
pubmed: 28643043
Neuroimage. 2012 Apr 15;60(3):1716-23
pubmed: 22306804
Neurology. 2002 Jun 25;58(12):1791-800
pubmed: 12084879
Alzheimers Dement. 2013 Jan;9(1):e-1-16
pubmed: 23360977
Rev Neurol. 1999 Jul 1-15;29(1):1-6
pubmed: 10528300
Ann Neurol. 2004 Mar;55(3):306-19
pubmed: 14991808

Auteurs

Renaud La Joie (R)

Memory & Aging Center, Department of Neurology, University of California, San Francisco, CA, USA. Electronic address: Renaud.lajoie@ucsf.edu.

Nagehan Ayakta (N)

Memory & Aging Center, Department of Neurology, University of California, San Francisco, CA, USA; Helen Wills Neuroscience Institute, University of California Berkeley, CA, USA.

William W Seeley (WW)

Memory & Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.

Ewa Borys (E)

Department of Pathology, Stritch School of Medicine, Loyola University, Maywood, IL, USA.

Adam L Boxer (AL)

Memory & Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.

Charles DeCarli (C)

Department of Neurology, University of California, Davis, CA, USA.

Vincent Doré (V)

Department of Molecular Imaging & Therapy, Centre for PET, Austin Health, Heidelberg, Victoria, Australia.

Lea T Grinberg (LT)

Memory & Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.

Eric Huang (E)

Memory & Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.

Ji-Hye Hwang (JH)

Memory & Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.

Milos D Ikonomovic (MD)

Department of Neurology, University of Pittsburgh, PA, USA; Department of Psychiatry, University of Pittsburgh, PA, USA.

Clifford Jack (C)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

William J Jagust (WJ)

Helen Wills Neuroscience Institute, University of California Berkeley, CA, USA.

Lee-Way Jin (LW)

Alzheimer's Disease Center, Department of Pathology, University of California Davis, CA, USA.

William E Klunk (WE)

Department of Neurology, University of Pittsburgh, PA, USA; Department of Psychiatry, University of Pittsburgh, PA, USA; Alzheimer's Disease Research Center, University of Pittsburgh, PA, USA.

Julia Kofler (J)

Department of Pathology, University of Pittsburgh, Pennsylvania, USA.

Orit H Lesman-Segev (OH)

Memory & Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.

Samuel N Lockhart (SN)

Helen Wills Neuroscience Institute, University of California Berkeley, CA, USA; Department of Internal Medicine, Division of Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Val J Lowe (VJ)

Department of Nuclear Medicine, Mayo Clinic, Rochester, MN, USA.

Colin L Masters (CL)

The Florey Institute, The University of Melbourne, Melbourne, Victoria, Australia.

Chester A Mathis (CA)

Department of Radiology, University of Pittsburgh, PA, USA.

Catriona L McLean (CL)

Department of Anatomical Pathology, Alfred Hospital, Melbourne, Australia.

Bruce L Miller (BL)

Memory & Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.

Daniel Mungas (D)

Department of Neurology, University of California, Davis, CA, USA.

James P O'Neil (JP)

Helen Wills Neuroscience Institute, University of California Berkeley, CA, USA; Biomedical Isotope Facility, MBIB Division, Lawrence Berkeley National Laboratory, CA, USA.

John M Olichney (JM)

Department of Neurology, University of California, Davis, CA, USA.

Joseph E Parisi (JE)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA; Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Ronald C Petersen (RC)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Howard J Rosen (HJ)

Memory & Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.

Christopher C Rowe (CC)

Department of Molecular Imaging & Therapy, Centre for PET, Austin Health, Heidelberg, Victoria, Australia.

Salvatore Spina (S)

Memory & Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.

Prashanthi Vemuri (P)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Victor L Villemagne (VL)

Department of Molecular Imaging & Therapy, Centre for PET, Austin Health, Heidelberg, Victoria, Australia; The Florey Institute, The University of Melbourne, Melbourne, Victoria, Australia.

Melissa E Murray (ME)

Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.

Gil D Rabinovici (GD)

Memory & Aging Center, Department of Neurology, University of California, San Francisco, CA, USA; Helen Wills Neuroscience Institute, University of California Berkeley, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH